Table 2 SABR Dose fractionations for different centres for 2 indications: 1) nodal recurrences, 2) recurrent primary tumours and 3) primary boost
SABR Treatment | Centre 1 | Centre 2 | Centre 3 | Centre 4 | Centre 5 | Centre 6 | Centre 7 | Centre 8 | Centre 9 | Centre 10 | Centre 11 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Nodal Recurrence | 8 Gy × 3 5 Gy × 5 | 5–8 Gy × 5 | 8 Gy × 3 | 5–8 Gy × 3–5 | 5–7 Gy × 3 | 8–10 Gy × 5 | 11–13 Gy × 3 7.6–8 Gy × 5 | 4 Gy × 3 6 Gy × 5 | 10 Gy × 3 | 5–6 Gy × 5 | 6–8 Gy × 5 |
Recurrent Primary Tumor | Does not treat | 5–8 Gy × 5 | 8 Gy × 3 | 5–8 Gy × 3–5 | 5 Gy × 4 5 Gy × 5 | 8–10 Gy × 5 | 11–13 Gy × 3 7.6–8 Gy × 5 | 4 Gy × 3 6 Gy × 5 | 10 Gy × 3 | 5–6 Gy × 5 | 6–8 Gy × 5 |
Primary Boost | NA | 5 Gy × 2–3 | NA | 5.5 Gy × 5 (median) | 5–7 Gy × 3 | 8 Gy × 5 | 5–8 Gy × 3–5 | NA | 7 Gy × 4 | 7 Gy × 4 | 5.5–6 Gy × 5 |